Samsung partners with Galeon to integrate AI and blockchain in medical imaging

Samsung Electronics has announced a strategic partnership with Galeon, a decentralized science (DeSci) protocol focused on healthcare innovation, on September 23, 2025.

The goal? To integrate artificial intelligence directly into Samsung’s ultrasound devices, leveraging Web3 principles to secure and share sensitive medical data.

A Bridge Between Medical Devices and Decentralized Networks

At the core of this alliance is Galeon’s blockchain-based electronic medical record system, already in use at 18 hospitals in France. These facilities, managing over 5 million patient records and supporting the work of 10,000 healthcare professionals, will feed Samsung’s AI algorithms with anonymized data.

The result: hospitals maintain control over their information while contributing to a collective training pool for AI, breaking away from traditional data silos.

Samsung’s ultrasound devices, enhanced with AI capabilities, will be able to stream data in real-time to Galeon’s decentralized infrastructure to continuously improve their performance.

Data Privacy and Sovereignty

The strength of Galeon lies in its approach: through blockchain, data is anonymized, tokenized, and compliant with regulations like GDPR. This addresses one of the biggest challenges in medical AI: the lack of reliable and accessible data.

This model is seen as a democratization of medical research, similar to initiatives in longevity and genetics.

A Global Impact on Healthcare Innovation

For Samsung, this partnership is part of a broader strategy: following its Web3 investments starting in 2022 and the acquisition of Xealth to connect clinical data to its Galaxy Watch, the company is taking a new step by hybridizing consumer electronics, health, and blockchain.

Analysts believe this model could create new revenue streams in the rapidly evolving field of decentralized health.

Of course, challenges remain: international interoperability, complex regulations, and scalability. However, the open-source ethics of DeSci may help overcome some of these obstacles.

Toward a New Era of Medical AI

Initial pilots between Samsung and Galeon are expected to quickly set the pace. By facilitating equitable and secure sharing of medical data, this initiative could reduce inequalities in research and speed up diagnosis.

In practice, this partnership positions Samsung as a pioneer of a new model of connected health, where AI continuously learns from real-world data while respecting patient confidentiality.

For industry leaders and tech strategists, this serves as a blueprint for the future: a medicine where security, efficiency, and collaboration take precedence in an increasingly data-driven world.